scholarly article | Q13442814 |
P50 | author | Lisa Bero | Q16192607 |
Brett D Thombs | Q42350951 | ||
Erick H Turner | Q58325540 | ||
Joel Lexchin | Q88126817 | ||
Michelle Roseman | Q125215088 | ||
P2093 | author name string | James C Coyne | |
P2860 | cites work | Epidemiology and reporting characteristics of systematic reviews | Q21144675 |
Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others | Q21563421 | ||
Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy | Q23791313 | ||
Partisan perspectives in the medical literature: a study of high frequency editorialists favoring hormone replacement therapy | Q24289488 | ||
CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials | Q24614627 | ||
Pharmaceutical industry sponsorship and research outcome and quality: systematic review | Q24673248 | ||
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration | Q27860581 | ||
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860868 | ||
Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation | Q28474127 | ||
Factors associated with results and conclusions of trials of thiazolidinediones | Q28475588 | ||
Scope and impact of financial conflicts of interest in biomedical research: a systematic review | Q29616086 | ||
Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ | Q33960572 | ||
Those who have the gold make the evidence: how the pharmaceutical industry biases the outcomes of clinical trials of medications | Q34025773 | ||
Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review | Q34105156 | ||
Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments | Q34169330 | ||
A new system for grading recommendations in evidence based guidelines | Q34332845 | ||
Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications | Q34534086 | ||
The reporting quality of meta-analyses improves: a random sampling study | Q34769829 | ||
Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review | Q35082900 | ||
Assessment of methodological quality of primary studies by systematic reviews: results of the metaquality cross sectional study | Q36092201 | ||
Relative citation impact of various study designs in the health sciences | Q36130841 | ||
Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort study | Q36248519 | ||
Pharmaceutical company funding and its consequences: a qualitative systematic review | Q36962660 | ||
Does the type of competing interest statement affect readers' perceptions of the credibility of research? Randomised trial | Q37268456 | ||
The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews | Q37692721 | ||
The impact of disclosing financial ties in research and clinical care: a systematic review | Q37737486 | ||
Does declaration of competing interests affect readers' perceptions? A randomised trial | Q39691480 | ||
Systems to rate the strength of scientific evidence | Q40643928 | ||
CONSORT for reporting randomised trials in journal and conference abstracts | Q56880300 | ||
Toward More Uniform Conflict Disclosures | Q57247850 | ||
The quality of drug studies published in symposium proceedings | Q71004282 | ||
How pharmaceutical industry funding affects trial outcomes: causal structures and responses | Q80770643 | ||
It's time to rebuild the evidence base | Q84196688 | ||
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e5155 | |
P577 | publication date | 2012-08-16 | |
P1433 | published in | The BMJ | Q546003 |
P1476 | title | Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study | |
P478 | volume | 345 |
Q34794434 | Association of industry sponsorship and positive outcome in randomised controlled trials in general and abdominal surgery: protocol for a systematic review and empirical study |
Q24658631 | Conflict of interest disclosure in biomedical research: a review of current practices, biases, and the role of public registries in improving transparency |
Q34523783 | Conflicts of interest and spin in reviews of psychological therapies: a systematic review |
Q37487299 | Conflicts of interest in biomedical publications: considerations for authors, peer reviewers, and editors. |
Q36391292 | Conflicts of interest in nutritional sciences: The forgotten bias in meta-analysis |
Q36585408 | Depression screening and mental health outcomes in children and adolescents: a systematic review protocol |
Q24289431 | Effects of screening for psychological distress on patient outcomes in cancer: a systematic review |
Q36887082 | Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials: overview of published comments and analysis of user practice in Cochrane and non-Cochrane reviews |
Q36951441 | Financial Relationships between Organizations That Produce Clinical Practice Guidelines and the Biomedical Industry: A Cross-Sectional Study |
Q60603546 | Has Cochrane lost its way? |
Q38193904 | Has industry funding biased studies of the protective effects of alcohol on cardiovascular disease? A preliminary investigation of prospective cohort studies |
Q36920494 | Industry influence in evidence production |
Q24202591 | Industry sponsorship and research outcome |
Q38186856 | Methodological quality of systematic reviews on influenza vaccination |
Q36263109 | Potential Conflict of Interest and Bias in the RACGP's Smoking Cessation Guidelines: Are GPs Provided with the Best Advice on Smoking Cessation for their Patients? |
Q91736607 | Reporting of financial conflicts of interest in meta-analyses of drug trials published in high-impact medical journals: comparison of results from 2017 to 2018 and 2009 |
Q47626625 | Scientism, conflicts of interest, and the marginalization of ethics in medical education. |
Q54373404 | Study sponsorship and the nutrition research agenda: analysis of randomized controlled trials included in systematic reviews of nutrition interventions to address obesity. |
Q24289237 | The cycle of bias in health research: a framework and toolbox for critical appraisal training |
Q38141169 | The evolution of assessing bias in Cochrane systematic reviews of interventions: celebrating methodological contributions of the Cochrane Collaboration |
Q24201550 | Why the Cochrane Risk of Bias Tool Should Include Funding Source as a Standard Item |
Search more.